PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.31, sa.3, ss.261-269, 2021 (SCI-Expanded)
Background: Genomic variations in mono-ADP ribosylhydrolase 2 (MACROD2) have been associated with autism spectrum disorder (ASD) in recent genome-wide studies and case reports. In this study, we aimed to evaluate the MACROD2 expression profile in patients with ASD.